At HIMSS, GE HealthCare and Mass General Brigham announced that they are integrating foundation models into their collaborative AI research and development. Foundation models could help developers create healthcare AI tools "10 times faster than in the past," according to Parminder Bhatia, GE HealthCare’s chief AI officer.
This year's ViVE conference featured a variety of news announcements — from company launches to new products to partnerships to acquisitions and more. In this list, MedCity News compiled short summaries for nine of the conference's most notable announcements.
At RSNA 2023, GE HealthCare announced the launch of a new AI suite designed to simplify radiologists’ workflows when reading mammograms and help them detect breast cancer in patients sooner. The new offering includes three AI tools made by iCAD.
Patients yearn for care experiences that are more convenient, personal and accessible. However, clinicians aren't doing a great job of delivering this kind of care, according to a new report. The staffing crisis has put clinicians under a lot of pressure — they feel they often don't have time to deliver adequate care of get effectively trained on how to use new technology.
Many experts think technology will help mitigate healthcare's burnout crisis and workforce shortage, but the healthcare industry still has a lot to figure out when it comes to choosing which tools to deploy and getting its workers on board with these new tools, according to a new report from GE HealthCare.
GE HealthCare recently announced plans to acquire Caption Health, a company that sells AI software designed to guide cardiac imaging. The company's guidance technology aims to make ultrasound exams easier and faster, as well as allow a broader set of healthcare professionals to conduct basic echocardiography exams.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Here is a selection of recent executive hires, departures and layoffs occurring across the healthcare industry.
GE Healthcare is preparing for its spinoff from GE, which is planned for the first week of January. The company’s split will allow it to operate under a new board, as well as manage its own capital. That capital will be primarily invested in acquisitions and research and development efforts, according to GE Healthcare's CEO for the U.S. and Canada.
With its two major announcements at the Global Health Conference & Exhibition in Orlando, the company signaled it is aiming to help providers access more in-depth, real-time patient data to improve clinical decision-making and care.
The company would become part of GE’s ultrasound business, expanding its capabilities to include surgical visualization. GE plans to spin out its healthcare division into a publicly traded company in 2023.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The spinoff, however late, promises to make investments in GE more pure plays, which investors find easier to understand and to value. But for GE Healthcare, the real growth will be in less acute settings, and GE needs to acknowledge that trend in their strategy.
Join our live webinar with top MedTech sales experts to learn how to succeed in the digital revolution of medical device and healthcare sales.
The academic medical center collaborated with GE Healthcare to set up the first virtual intensive care unit program in the state, which will help the organization extend its critical care expertise across rural areas and manage bed capacity amid climbing Covid-19 cases.
The technology company is launching an alliance connecting the AI-driven medical imaging startups in its accelerator program to the GE Healthcare Edison Developer Program and Nuance AI Marketplace for diagnostic imaging.
The cancer and cardiovascular care provider has teamed up with GE Healthcare, granting its 440 centers in the U.S., U.K., Spain and Australia access to GE equipment and services. The organizations will also explore research opportunities.
